Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, especially for cancers where procedure selections remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/naga-revenue-declines-post-merger-but-ebitda-margin-improves/